Effect of radiotherapy and other treatmentrelated factors on mid to longterm cognitive sequelae in lowgrade gliomas: a comparative study

M. Klein*, J.J. Heimans, N.K. Aaronson, H.M van der Ploeg, J. Grit, M. Muller, T.J. Postma, J.J. Mooij, R.H. Boerman, G.J., I.mhoff, G.W va Ossenkoppele, A.W. Dekker, J. Jolles, B.J. Slotman, H. Struikmans, M.J.B. Taphoorn

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

742 Downloads (Pure)


Background Because survival benefits of treatment with radiotherapy are questionable and such treatment can cause substantial damage to the brain over time, the optimum management strategy for low-grade gliomas remains controversial. We aimed to identify the specific effects of radiotherapy on objective and self-reported cognitive function, and on cognitive deterioration over time, in patients with low-grade gliomas treated with early radiotherapy. Methods 195 patients with low-grade glioma (of whom 104 had received radiotherapy 1-22 years previously) were compared with 100 low-grade haematological patients and 195 healthy controls. Our analyses aimed to differentiate between the effects of the tumour (eg, disease duration, lateralisation) and treatment effects (neurosurgery, radiotherapy, antiepileptic drugs) on cognitive function and on relative risk of cognitive disability. Findings Low-grade glioma patients had lower ability in all cognitive domains than did low-grade haematological patients, and did even less well by comparison with healthy controls. Use of radiotherapy was associated with poorer cognitive function; however, cognitive disability in the memory domain was found only in radiotherapy patients who received fraction doses exceeding 2 Gy. Antiepileptic drug use was strongly associated with disability in attentional and executive function. Interpretation Our findings suggest that the tumour itself has the most deleterious effect on cognitive function and that radiotherapy mainly results in additional long-term cognitive disability when high fraction doses are used.
Original languageEnglish
Pages (from-to)1361-1368
Volume36 9343
Publication statusPublished - 1 Jan 2002

Cite this